secwatch / observer

Material Agreements

Entry into or termination of material definitive agreements (Items 1.01/1.02).

8-K items 1.01, 1.02 JSON
Apollo Debt Solutions BDC

Apollo Debt Solutions BDC entered into Bald Eagle Funding Credit Agreement with Bank of America, N.A., as administrative agent, Citibank, N.A., as collateral agent and collateral custodian, Virtus Group, LP, as collateral administrator and the lenders party thereto valued at $500 million (effective 2026-03-09).

“On March 9, 2026 (the “Closing Date”), Bald Eagle Funding LLC (“Bald Eagle Funding”), a Delaware limited liability company and newly formed wholly-owned subsidiary of Apollo Debt Solutions BDC, a Delaware statutory trust (the “Company” or “us”), entered into a credit agreement (the “Bald Eagle Funding Credit Agreement”), with Bald Eagle Funding, as borrower, Bank of America, N.A., as administrative agent (the “Administrative Agent”), Citibank, N.A., as collateral agent and collateral custodian, Virtus Group, LP, as collateral administrator and the lenders party thereto.”
SPWR SunPower Inc.

SunPower Inc. amended Amendment and Agreement (the "Sunder Amendment") with Chicken Parm Pizza LLC (effective 2026-03-05).

“On March 5, 2026, in connection with the transactions under the Purchase Agreement and the Debenture, the Company and Chicken Parm Pizza LLC (the “ Sunder Member ”) entered into an Amendment and Agreement (the “ Sunder Amendment ”) relating to (i) the Membership Interest Purchase Agreement,”
SPWR SunPower Inc.

SunPower Inc. entered into Registration Rights Agreement with YA II PN, LTD. (effective 2026-03-06).

“In connection with the Purchase Agreement and the Debenture, the Company entered into a registration rights agreement (the “ Registration Rights Agreement ”) with the Investor, pursuant to which the Company agreed to file a registration statement registering the resale of the Common Stock underlying the Debenture and the Common Stock subject to advances pursuant to the SEPA.”
SPWR SunPower Inc.

SunPower Inc. entered into Debenture with YA II PN, LTD. valued at $10,000,000 (effective 2026-03-06).

“Pursuant to the Purchase Agreement, the Investor purchased and the Company issued a convertible debenture in the principal amount of $10,000,000 (the “ Debenture ”).”
SPWR SunPower Inc.

SunPower Inc. entered into Purchase Agreement with YA II PN, LTD. valued at $10,000,000 (effective 2026-03-06).

“On March 6, 2026 (the “ Effective Date ”), SunPower Inc. (the “ Company ”) entered into a Purchase Agreement (the “ Purchase Agreement ”) with YA II PN, LTD., a Cayman Islands exempt limited company (the “ Investor ”).”
CLDI Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc. entered into Warrant Agency Agreement with Equiniti Trust Company, LLC (effective 2026-03-06).

“On March 6, 2026, the Company also entered into a warrant agency agreement (the “Warrant Agency Agreement”) with Equiniti Trust Company, LLC, as warrant agent (the “Warrant Agent”).”
CLDI Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc. entered into Underwriting Agreement with Ladenburg Thalmann & Co. Inc. valued at approximately $6.03 million (effective 2026-03-06).

“On March 6, 2026, Calidi Biotherapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Ladenburg Thalmann & Co. Inc., as sole underwriter (“Underwriter”), in connection with the issuance and sale (the “Offering”) of: (i) 2,278,731 common stock units (“Common Stock Units”), which includes 1,575,000 Common Stock Units purchased pursuant to the exercise, in full, of the Over-Allotment Option and (ii) 9,815,900 pre-funded warrant units (“Pre-Funded Units”), resulting in gross proceeds of approximately $6.03 million, before deducting underwriting discounts and commissions and other estimated offering expenses.”
CERO CERO THERAPEUTICS HOLDINGS, INC.

CERO THERAPEUTICS HOLDINGS, INC. entered into Convertible Promissory Note with Keystone Capital Partners, LLC valued at Purchase price $750,000; principal face value $937,500; maximum aggregate borrowings $1,000,000; int (effective 2026-03-06).

“On March 6, 2026, CERo Therapeutics Holdings, Inc., a Delaware corporation (the “Company”) issued and sold a convertible promissory note for a purchase price of $750,000, having a principal face value of $937,500 (the “Note”) to Keystone Capital Partners, LLC (“Lender”).”
Yotta Acquisition Corp

Yotta Acquisition Corp terminated Business Combination Agreement with DRIVEiT Financial Auto Group, Inc. and the other parties thereto (effective 2026-03-04).

“On March 4, 2026, Yotta Acquisition Corporation, a Delaware corporation (the "Company"), provided written notice of its election to terminate that certain Business Combination Agreement, dated as of August 20, 2024 (the "Business Combination Agreement"), by and among the Company and DRIVEiT Financial Auto Group, Inc. and the other parties thereto.”
HLEO Helio Corp /FL/

Helio Corp /FL/ entered into Securities Purchase Agreement with an investor valued at $931,500 (effective 2026-03-05).

“On March 5, 2026, Helio Corporation (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with an investor (the “ Purchaser ”), pursuant to which the Company sold to the Purchaser 1,000 shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “ Series B Preferred Stock ”), for an aggregate purchase price of $931,500.”
WGRX Wellgistics Health, Inc.

Wellgistics Health, Inc. entered into Interim Commercialization and Revenue Share Agreement with Kare PharmTech LLC (effective 2026-03-06).

“On March 6, 2026, Wellgistics Health, Inc. (the “Company”), entered into an Interim Commercialization and Revenue Share Agreement (the “Revenue Share Agreement”) with Kare PharmTech LLC”
QSEA Quartzsea Acquisition Corp

Quartzsea Acquisition Corp amended Amendment No. 1 to the Underwriting Agreement with Polaris Advisory Partners, LLC (f/k/a SPAC Advisory Partners), a division of Kingswood Capital Partners LLC (effective 2026-03-03).

“On March 3, 2026, Quartzsea Acquisition Corporation (the “Company”) entered into Amendment No. 1 to the Underwriting Agreement (the “Amendment”) with Polaris Advisory Partners, LLC (f/k/a SPAC Advisory Partners), a division of Kingswood Capital Partners LLC, as representative of the several underwriters (the “Representative”), and Kingswood Capital Partners LLC.”
ETS Elite Express Holding Inc.

Elite Express Holding Inc. entered into Stock Purchase Agreement with eight non-U.S. investors valued at aggregate gross proceeds of $8,000,000 (effective 2026-03-10).

“On March 10, 2026, Elite Express Holding Inc., a Delaware corporation (the “Company” ), entered into a Stock Purchase Agreement (the “Purchase Agreement” ) with eight non-U.S. investors (the “Purchasers” ), pursuant to which the Company agreed to issue and sell in a private placement offering (the “Private Placement” ) an aggregate of 32,000,000 shares (the “Shares” ) of the Company's Class A Common Stock, $0.000001 par value per share, at a purchase price per share of $0.25, for aggregate gross proceeds of $8,000,000.”
QUMS Quantumsphere Acquisition Corp

Quantumsphere Acquisition Corp amended Amendment No. 1 to the Underwriting Agreement with Polaris Advisory Partners, LLC (as representative of the several underwriters) and Kingswood Capital Partners LLC (effective 2026-03-03).

“On March 3, 2026, Quantumsphere Acquisition Corporation (the “Company”) entered into Amendment No. 1 to the Underwriting Agreement (the “Amendment”) with Polaris Advisory Partners, LLC, a division of Kingswood Capital Partners LLC, as representative of the several underwriters (the “Representative”), and Kingswood Capital Partners LLC.”
EDUC EDUCATIONAL DEVELOPMENT CORP

EDUCATIONAL DEVELOPMENT CORP entered into Loan Agreement with Regent valued at principal amount up to $2,000,000 (effective 2026-03-06).

“On March 6, 2026, Educational Development Corporation (the “Company”) executed a Credit Agreement (“Loan Agreement”) with Regent (the “Lender”). The Loan Agreement establishes a revolving promissory note in the principal amount up to $2,000,000 (the “Revolving Loan”).”
UNF UNIFIRST CORP

UNIFIRST CORP entered into Agreement and Plan of Merger with Cintas Corporation, Bruin Merger Sub I, Inc., Bruin Merger Sub II, LLC (effective 2026-03-10).

“On March 10, 2026, UniFirst Corporation, a Massachusetts corporation (the “ Company ” or “ UniFirst ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with (i) Cintas Corporation, a Washington corporation (“ Parent ” or “ Cintas ”), (ii) Bruin Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of Cintas (“ Merger Sub Inc. ”), and (iii) Bruin Merger Sub II, LLC, a Delaware limited liability company and a wholly owned subsidiary of Cintas (“ Merger Sub LLC ”).”
CTAS CINTAS CORP

CINTAS CORP entered into Agreement and Plan of Merger with UniFirst Corporation valued at $155 in cash and 0.7720 shares of Cintas Common Stock (effective 2026-03-10).

“On March 10, 2026, Cintas Corporation, a Washington corporation (“Cintas”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with (i) UniFirst Corporation, a Massachusetts corporation (“UniFirst”), (ii) Bruin Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of Cintas (“Merger Sub Inc.”), and (iii) Bruin Merger Sub II, LLC, a Delaware limited liability company and a wholly owned subsidiary of Cintas (“Merger Sub LLC”).”
ENZN Viskase Holdings, Inc.

Viskase Holdings, Inc. amended Ninth Amendment to the Section 382 Rights Agreement with Continental Stock Transfer & Trust Company valued at Extended the Final Expiration Date from noon, New York City time, on March 11, 2026 to noon, New Yor (effective 2026-03-10).

“On March 10, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Ninth Amendment to the Section 382 Rights Agreement (the “ Ninth Amendment ”), which amends the Section 382 Rights Agreement, dated as of August 14, 2020 (the “ Rights Agreement ”), by and between the Company and Continental Stock Transfer & Trust Company, as rights agent.”
HBT HBT Financial, Inc.

HBT Financial, Inc. entered into Indenture with UMB, N.A. (effective 2026-03-11).

“The Notes were issued under an Indenture, dated March 11, 2026 (the “Indenture”), by and between the Company and UMB, N.A., as trustee (the “Trustee”).”
HBT HBT Financial, Inc.

HBT Financial, Inc. entered into Registration Rights Agreement with certain institutional accredited investors and qualified institutional buyers (effective 2026-03-11).

“On March 11, 2026, in connection with the sale and issuance of the Notes, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchasers.”
HBT HBT Financial, Inc.

HBT Financial, Inc. entered into Subordinated Note Purchase Agreement with certain institutional accredited investors and qualified institutional buyers valued at $85.0 million (effective 2026-03-11).

“On March 11, 2026, HBT Financial, Inc. (the “Company”) entered into a Subordinated Note Purchase Agreement (the “Purchase Agreement”) with certain institutional accredited investors and qualified institutional buyers (collectively, the “Purchasers”) pursuant to which the Company sold and issued $85.0 million in aggregate principal amount of its 5.75% Fixed-to-Floating Rate Subordinated Notes due 2036”
JVA COFFEE HOLDING CO INC

COFFEE HOLDING CO INC amended Twelfth Loan Modification Agreement with Webster Bank (effective 2026-03-04).

“On March 4, 2026, Borrowers entered into the Twelfth Loan Modification Agreement (the “Amendment”) with the Lender, which amended the Loan Agreement to provide for a new loan maturity date of December 28, 2026.”
USEG US ENERGY CORP

US ENERGY CORP entered into Underwriting Agreement with Roth Capital Partners, LLC (effective 2026-03-09).

“On March 9, 2026, U.S. Energy Corp. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Roth Capital Partners, LLC (the “ Underwriter ”), relating to the previously announced underwritten offering of 8,800,000 shares of common stock, par value $0.01 per share, of the Company (the “ Common Stock ”), at a price to the public of $1.00 per share (such offering, the “ Offering ”).”
SFST SOUTHERN FIRST BANCSHARES INC

SOUTHERN FIRST BANCSHARES INC amended Modification Agreement with TIB, National Association valued at up to an aggregate principal amount of $15.0 million (effective 2026-03-05).

“On March 5, 2026, Southern First Bancshares, Inc. (the “Company”) entered into a Modification of Loan (the “Modification Agreement”) amending both the Loan Agreement (“Loan Agreement”) and the Promissory Note (the “Promissory Note”), each dated as of December 28, 2023, by and between the Company and TIB, National Association (the “Lender”).”
FIS Fidelity National Information Services, Inc.

Fidelity National Information Services, Inc. entered into Underwriting Agreement with several underwriters named therein valued at €500,000,000 Floating Rate Senior Notes due 2028, €500,000,000 3.450% Senior Notes due 2030 (effective 2026-03-05).

“Closing of Euro Notes Offering Also on March 10, 2026, FIS completed the issuance and sale of its previously announced offering of Euro-denominated senior notes, consisting of €500,000,000 in aggregate principal amount of Floating Rate Senior Notes due 2028 (the “2028 Floating Rate Euro Notes”) and €500,000,000 in aggregate principal amount of 3.450% Senior Notes due 2030 (the “2030 Fixed Rate Euro Notes” and, collectively with the 2028 Floating Rate Euro Notes, the “Euro Notes”).”
FIS Fidelity National Information Services, Inc.

Fidelity National Information Services, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Wells Fargo Securities, LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC and TD Securities (USA) LLC valued at $2,000,000,000 4.450% Senior Notes due 2028, $2,300,000,000 4.550% Senior Notes due 2029, $500,000,0 (effective 2026-03-04).

“Closing of USD Notes Offering On March 10, 2026, Fidelity National Information Services, Inc. (“FIS”) completed the issuance and sale of its previously announced offering of U.S. dollar-denominated senior notes, consisting of $2,000,000,000 in aggregate principal amount of 4.450% Senior Notes due 2028 (the “2028 Fixed Rate Notes”), $2,300,000,000 in aggregate principal amount of 4.550% Senior Notes due 2029 (the “2029 Fixed Rate Notes”), $500,000,000 in aggregate principal amount of Floating Rate Senior Notes due 2029 (the “2029 Floating Rate Notes”) and $2,000,000,000 in aggregate principal amount of 4.800% Senior Notes due 2031 (the “2031 Fixed Rate Notes” and, collectively with the 2028 Fixed Rate Notes, the 2029 Fixed Rate Notes and the 2029 Floating Rate Notes, the “USD Notes”).”
APLD Applied Digital Corp.

Applied Digital Corp. entered into Indenture with Wilmington Trust, National Association valued at $2.15 billion (effective 2026-03-10).

“ccount) in accordance with the provisions of the indenture governing the notes, and to pay related fees and expenses, including transaction”
RCKT ROCKET PHARMACEUTICALS, INC.

ROCKET PHARMACEUTICALS, INC. terminated Prior Sales Agreement with Cowen and Company, LLC, an affiliate of TD Securities (USA) LLC (effective 2026-03-10).

“Upon entry into the Sales Agreement, the Company terminated its prior “at-the-market” sales agreement with Cowen and Company, LLC, an affiliate of TD Securities (USA) LLC, dated February 28, 2022, (the “Prior Sales Agreement”), as amended by Amendment No. 1 to the Prior Sales Agreement, dated as of September 12, 2023 (“Amendment No. 1”), pursuant to which the Company could offer and sell, from time to time through Cowen and Company, LLC, as its agent, shares of the Company’s common stock.”
RCKT ROCKET PHARMACEUTICALS, INC.

ROCKET PHARMACEUTICALS, INC. entered into Sales Agreement with Cantor Fitzgerald & Co. valued at $100,000,000 (effective 2026-03-10).

“On March 10, 2026, Rocket Pharmaceuticals, Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co. (the “Sales Agent”), with respect to an at-the-market offering program pursuant to which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.01 per share, having an aggregate offering price of up to $100,000,000 (the “Shares”), through the Sales Agent.”
Novelis Inc.

Novelis Inc. entered into Loan Agreement with The Industrial Development Authority of Baldwin County valued at $225 million (effective 2026-03-01).

“the Company entered into a Loan Agreement, dated as of March 1, 2026 (the “Loan Agreement”), with The Industrial Development Authority of Baldwin County (the “Issuer”), whereby the Issuer loaned $225 million in proceeds from the sale of Solid Waste Disposal Revenue Bonds (Novelis Corporation Project), Series 2026A, in the aggregate principal amount of $225 million (the “Bonds”), to the Company”
CETY Clean Energy Technologies, Inc.

Clean Energy Technologies, Inc. entered into Securities Purchase Agreement with Noblebear Investment Holdings LLC with Noblebear Investment Holdings LLC valued at principal amount $660,000; convertible note; interest 10% per annum (effective 2026-03-06).

“On or about March 6, 2026, in consideration of (i) $604,469 in funding previously advanced to the Company by Mega Sincere Holdings Limited (“ Mega ”), a company organized under the laws of the British Virgin Islands, and its affiliates, and (ii) $600,000 in funding previously advanced to the Company by Noblebear Investment Holdings LLC (“ Noblebear ”), a company organized under the laws of the California and controlled by a Company shareholder and related party, the Company entered into securities purchase agreements with Mega and Noblebear (the “ Mega and Noblebear SPA’s ”) and issued Mega and Noblebear convertible promissory notes in the principal amounts of $664,916 and $660,000, respectively”
CETY Clean Energy Technologies, Inc.

Clean Energy Technologies, Inc. entered into Securities Purchase Agreement with Mega Sincere Holdings Limited with Mega Sincere Holdings Limited valued at principal amount $664,916; convertible note; interest 10% per annum (effective 2026-03-06).

“On or about March 6, 2026, in consideration of (i) $604,469 in funding previously advanced to the Company by Mega Sincere Holdings Limited (“ Mega ”), a company organized under the laws of the British Virgin Islands, and its affiliates, and (ii) $600,000 in funding previously advanced to the Company by Noblebear Investment Holdings LLC (“ Noblebear ”), a company organized under the laws of the California and controlled by a Company shareholder and related party, the Company entered into securities purchase agreements with Mega and Noblebear (the “ Mega and Noblebear SPA’s ”) and issued Mega and Noblebear convertible promissory notes in the principal amounts of $664,916 and $660,000, respectively”
CETY Clean Energy Technologies, Inc.

Clean Energy Technologies, Inc. entered into Securities Purchase Agreement with 1800 Diagonal Lending LLC with 1800 Diagonal Lending LLC valued at principal amount $147,840; purchase price $132,000; net funding $125,000 (effective 2026-03-04).

“On or about March 4, 2026, Clean Energy Technologies, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ 1800 SPA ”) with 1800 Diagonal Lending LLC, a Virginia limited liability company (“ 1800 Diagonal ”), pursuant to which the Company sold, and 1800 Diagonal purchased, a convertible promissory note in the principal amount of $147,840 (the “ 1800 Note ”) for a purchase price of $132,000”
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXTE BIOTECHNOLOGY HOLDINGS, INC. amended Amended and Restated Share Exchange Agreement with Orbit Capital Inc. valued at Amends and restates the Share Exchange Agreement dated November 21, 2025 (effective 2025-11-21).

“On March 6, 2026, Lixte Biotechnology Holdings, Inc., (the “Company”), Liora Technologies Europe Ltd, a subsidiary of the Company (“Liora”) and Orbit Capital Inc., (“Orbit”), entered into an Amended and Restated Share Exchange Agreement with an effective date of November 21, 2025 (the A&R Agreement).”
KDP Keurig Dr Pepper Inc.

Keurig Dr Pepper Inc. amended Amendment No. 1 with Morgan Stanley Senior Funding, Inc. (effective 2026-03-06).

“On March 6, 2026, Keurig Dr Pepper Inc. (“KDP” or the “Company”) entered into an amendment (the “Amendment No. 1”) to its Term Loan Agreement, dated as of December 18, 2025”
NXGL NEXGEL, INC.

NEXGEL, INC. entered into Agreement with Celularity, Inc. valued at up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million (effective 2026-03-06).

“On March 6, 2026, NexGel, Inc., a Delaware corporation (the “ Company ”), entered into an Asset Purchase and Exclusive License Agreement (the “ Agreement ”) with Celularity, Inc., a Delaware corporation (the “ Licensor ”), whereby the Licensor granted to the Company an exclusive license to its commercial-stage biomaterials portfolio and certain development-stage programs as more fully described in the Agreement and the Licensor agreed to sell to the Company assets related to the portfolio (collectively, the “ Business ”). Consideration for the Business will consist of up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million upfront payment and (ii) an additional $20.0 million in potential milestone payments based on net sales targets related to the Business.”
XWIN XMax Inc.

XMax Inc. entered into Securities Purchase Agreement with certain purchasers identified on the signature pages thereto valued at aggregate gross proceeds to the Company of $35,955,000 (effective 2026-03-09).

“On March 9, 2026, XMax Inc. (the “Company”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain purchasers identified on the signature pages thereto (the “ Purchasers ”), pursuant to which the Company will sell to the Purchasers in a registered direct offering, an aggregate of 8,500,000 shares (the “ Shares ”) of its common stock, par value $0.001 per share (“ Common Stock ”) at a purchase price of $4.23 per share, for aggregate gross proceeds to the Company of $35,955,000, before deducting offering expenses payable by the Company.”
Eventbrite, Inc.

Eventbrite, Inc. terminated Credit Agreement with Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as the administrative agent and collateral agent (effective 2025-08-06).

“the Company repaid all obligations outstanding under, and concurrently terminated, the Credit Agreement, dated as of August 6, 2025 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time), by and among the Company, the guarantors party thereto from time to time, the banks and other financial institutions or entities party thereto from time to time, and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as the administrative agent and collateral agent”
CVSI CV Sciences, Inc.

CV Sciences, Inc. amended Agreement with an institutional investor ("Investor") valued at aggregate outstanding principal amount of $2,256,000 (effective 2026-03-04).

“On March 4, 2026, the Company and the Investor entered into an agreement (the “Agreement”) to, among other things, amend and restate the Amended Original Note and the Second Note”
NINE Nine Energy Service, Inc.

Nine Energy Service, Inc. entered into Exit Loan and Security Agreement with White Oak Commercial Finance, LLC valued at $135.0 million (effective 2026-03-05).

“On the Plan Effective Date, pursuant to the Plan, the Company entered into a loan and security agreement (the “Exit Loan and Security Agreement”) with White Oak Commercial Finance, LLC, as agent, and the lenders from time to time party thereto, and on the terms and subject to the conditions set forth therein, each DIP Lender exchanged and converted on a cashless basis all of its loans under the DIP Loan and Security Agreement for loans under the Exit Loan and Security Agreement.”
TXO TXO Partners, L.P.

TXO Partners, L.P. entered into Purchase Agreement with CTOC Energy, LLC valued at approximately $123.5 million in aggregate consideration (effective 2026-03-10).

“On March 10, 2026, Cross Timbers Energy, LLC (“Cross Timbers”), a joint venture in which TXO Partners, L.P. (the “Partnership”) holds a 50% interest, announced that it has executed purchase and sale agreements with multiple private buyers to sell oil and gas properties totaling approximately $200 million in aggregate consideration (collectively, the “Cross Timbers Transactions”), including a purchase and sale agreement (the “Purchase Agreement”) with CTOC Energy, LLC (“CTOC”) for approximately $123.5 million in aggregate consideration.”
GLPI Gaming & Leisure Properties, Inc.

Gaming & Leisure Properties, Inc. terminated Term Loan Credit Agreement (the "2022 Term Loan Agreement") with Wells Fargo Bank, National Association, as administrative agent, and the several banks and other financial institutions or entities party thereto (effective 2026-03-04).

“On March 4, 2026, GLP repaid in full all outstanding obligations under the Term Loan Credit Agreement among GLP, Wells Fargo Bank, National Association, as administrative agent, and the several banks and other financial institutions or entities party thereto, dated as of September 2, 2022 (the “2022 Term Loan Agreement”).”
GLPI Gaming & Leisure Properties, Inc.

Gaming & Leisure Properties, Inc. amended Amendment No. 3 (the "Amendment") with Wells Fargo Bank, National Association, as administrative agent, and the several banks and other financial institutions or entities party thereto valued at $679,000,000 (effective 2026-03-04).

“On March 4, 2026, GLP Capital, L.P. (“GLP”), the operating partnership of Gaming and Leisure Properties, Inc. (“GLPI”), entered into Amendment No. 3 (the “Amendment”) to the Credit Agreement among GLP, Wells Fargo Bank, National Association, as administrative agent, and the several banks and other financial institutions or entities party thereto, dated as of May 13, 2022 (the “Credit Agreement”).”
ATPC Agape ATP Corp

Agape ATP Corp entered into Collaboration Agreement with Citadel Investment LLC (effective 2026-03-06).

“On March 6, 2026, Agape ATP Corporation (the “Company”) through its subsidiary ATPC Green Energy Sdn. Bhd. (“ATPC Green Energy”), entered into a non-exclusive collaboration agreement (“Collaboration Agreement”) with Citadel Investment LLC”
ZCSH Grayscale Zcash Trust (ZEC)

Grayscale Zcash Trust (ZEC) entered into Second Amended and Restated Declaration of Trust and Trust Agreement with CSC Delaware Trust Company (effective 2026-03-09).

“On March 9, 2026, following approval of the Proposals (as defined below), Grayscale Investments Sponsors, LLC, the sponsor (the “Sponsor”) of Grayscale Zcash Trust (ZEC) (the “Trust”), and CSC Delaware Trust Company, the trustee (the “Trustee”) of the Trust, entered into the Second Amended and Restated Declaration of Trust and Trust Agreement, dated as of March 9, 2026 (the “Second A&R Trust Agreement”).”
AMCR Amcor plc

Amcor plc entered into Indenture with U.S. Bank Trust Company, National Association valued at $1,500,000,000 aggregate principal amount (comprising $750,000,000 of 4.250% Guaranteed Senior Notes (effective 2026-03-10).

“completed the offer and sale by the Issuer of $750,000,000 aggregate principal amount of its 4.250% Guaranteed Senior Notes due 2029”
CELU Celularity Inc

Celularity Inc entered into Asset Purchase and Exclusive License Agreement with NexGel, Inc. valued at up to $35.0 million in cash (effective 2026-03-06).

“On March 6, 2026, Celularity Inc., a Delaware corporation (the “Company”), entered into an Asset Purchase and Exclusive License Agreement (the “Agreement”) with NexGel, Inc., a Delaware corporation (the “Licensee”), whereby the Company granted to the Licensee an exclusive license to its commercial-stage biomaterials portfolio and certain development-stage programs as more fully described in the Agreement and the Company agreed to sell to the Licensee assets related to the portfolio (collectively, the “Business”). Consideration for the Business will consist of up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million upfront payment and (ii) an additional $20.0 million in potential milestone payments based on net sales targets related to the Business.”
SHPH Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc. entered into Placement Agency Agreement with E.F. Hutton & Co. valued at Placement agency agreement on a reasonable best-efforts basis, with cash fee of 4.0% of gross procee (effective 2026-03-05).

“On March 5, 2026, the Company entered into a Placement Agency Agreement (the “Placement Agency Agreement”) with E.F. Hutton & Co., as placement agent (the “Placement Agent”), pursuant to which the Placement Agent agreed to act as the Company’s exclusive placement agent in connection with the Offering.”
SHPH Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc. entered into Securities Purchase Agreement with the purchasers named therein valued at The Company agreed to issue and sell 2,238,800 shares of common stock and pre-funded warrants to pur (effective 2026-03-05).

“In connection with the Offering, the Company entered into a Securities Purchase Agreement, dated March 5, 2026 (the “Purchase Agreement”), by and among the Company and the purchasers named therein, pursuant to which the Company agreed to issue and sell the shares of Common Stock and Pre-Funded Warrants.”
PASG Passage BIO, Inc.

Passage BIO, Inc. terminated Hopewell Lease Termination Agreement with Hopewell Campus Owner LLC valued at termination fee of approximately $4.8 million plus accrued rent through February 14, 2026 (effective 2026-03-04).

“On March 4, 2026, Passage Bio, Inc. (the "Company") and Hopewell Campus Owner LLC (the "Landlord") entered into a lease termination agreement (the "Termination Agreement") with respect to that certain lease agreement dated December 15, 2020 between the Company and Landlord (the "Hopewell Lease").”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.